The University of Texas Medical Branch at Galveston, which was selected by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to conduct pediatric vaccine trials for the H1N1 (swine flu) virus will begin those trials on Friday, Aug. 28.
Dr. Christine Turley, the principal investigator on the UTMB project, said the virus potentially could affect younger people particularly hard and that there could be another outbreak of the flu now that school has begun, making the trials even more important to families across the nation.
The study will measure the body’s immune response to the investigational H1N1 flu vaccine as well as its safety. In addition, the research will help determine how and when the H1N1 flu shot should be given with the seasonal flu shot to make it most effective.
To learn more about the H1N1 vaccine research being conducted at UTMB, please send an e-mail to firstname.lastname@example.org or call Karen Waterman, Carrie Harrington or Diane Barrett at 409-772-1696.